Rifadin IV Intravenous and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Rifadin IV Intravenous and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: rifampin
Brand name: Rifadin IV, Rifadin, Rimactane
Synonyms: Rifadin IV (Intravenous), Rifadin IV
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Rifadin IV Intravenous-Tilia Fe
- Rifadin IV Intravenous-Tiludronate
- Rifadin IV Intravenous-Timentin
- Rifadin IV Intravenous-Timentin Add-Vantage
- Rifadin IV Intravenous-Timentin Injection
- Rifadin IV Intravenous-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Rifamate
- Tildrakizumab-asmn Subcutaneous-Rifampin
- Tildrakizumab-asmn Subcutaneous-Rifampin and Isoniazid
- Tildrakizumab-asmn Subcutaneous-Rifampin Capsules
- Tildrakizumab-asmn Subcutaneous-Rifampin Injection
- Tildrakizumab-asmn Subcutaneous-Rifampin Intravenous